Работы, на которые ссылается эта работа

Работ: 189

Работа: Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Marina Colombo, Graça Raposo, Clotilde Théry
Обзорная статья2014Цитирований: 12
ABI
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
Обзорная статья2012Цитирований: 7
ABI
Extracellular vesicles: Exosomes, microvesicles, and friends
Graça Raposo, Willem Stoorvogel
Обзорная статья2013Цитирований: 5
ABI
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje, Jesús G. Berdeja, Yi Lin +20
Статья2019Цитирований: 4
ABI
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
Wenyan Fu, Changhai Lei, Shuowu Liu +12
Статья2019Цитирований: 4
ABI
Delivery technologies for cancer immunotherapy
Rachel Riley, Carl H. June, Róbert Langer +1
Обзорная статья2019Цитирований: 3
ABI
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Philip W. Kantoff, Celestia S. Higano, Neal D. Shore +10
Статья2010Цитирований: 3
ABI
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp, Michael Kalos, David M. Barrett +10
Статья2013Цитирований: 3
ABI
CTLA-4 and PD-1 Pathways
Elizabeth I. Buchbinder, Anupam M. Desai
Обзорная статья2015Цитирований: 3
ABI
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dai Fukumura, Jonas Kloepper, Zohreh Amoozgar +2
Обзорная статья2018Цитирований: 3
ABI
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo, Brian Ruffell
Обзорная статья2019Цитирований: 3
ABI
Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Ju‐Yeun Lee, Hyun Tae Lee, Woo‐Ri Shin +11
Статья2016Цитирований: 2
ABI
Going viral with cancer immunotherapy
Brian D. Lichty, Caroline J. Breitbach, David F. Stojdl +1
Обзорная статья2014Цитирований: 2
ABI
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Caroline J. Breitbach, Rozanne Arulanandam, Naomi De Silva +15
Статья2013Цитирований: 2
ABI
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio +26
Статья2015Цитирований: 2
ABI
Viral vectors: a look back and ahead on gene transfer technology.
Laura Vannucci, Michele Lai, Flavia Chiuppesi +2
Статья2013Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 2
ABI
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal +3
Обзорная статья2019Цитирований: 2
ABI
Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold
Thanh Loc Nguyen, Bong Geun, Young‐Jin Choi +2
Статья2020Цитирований: 2
ABI
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen, Ira Mellman
Обзорная статья2013Цитирований: 2
ABI
Cancer immunotherapy comes of age
Ira Mellman, George Coukos, Glenn Dranoff
Обзорная статья2011Цитирований: 2
ABI
The future of immune checkpoint therapy
Padmanee Sharma, James P. Allison
Обзорная статья2015Цитирований: 2
ABI
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Mei‐Hwei Chang, San‐Lin You, Chien‐Jen Chen +9
Статья2009Цитирований: 2
ABI
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi, Siok‐Keen Tey, Gianpietro Dotti +17
Статья2011Цитирований: 2
ABI
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
G. Fyfe, Richard I. Fisher, S A Rosenberg +3
Статья1995Цитирований: 2
ABI